Olema Pharmaceuticals, Inc. (OLMA)

Olema Pharmaceuticals Market Cap

Olema Pharmaceuticals has a market cap or net worth of $569.21 million as of April 30, 2024. Its market cap has increased by 237.61% in one year.

• Market Cap: 569.21M
• Enterprise Value: 308.70M
• 1-Year Change: 237.61%
• Ranking: #2856
• Category: Small-Cap
• Stock Price: $10.19

Market Cap Chart

Since the IPO on November 19, 2020, Olema Pharmaceuticals's market cap has decreased from $731.88M to $569.21M, a decrease of -22.23%. That is a compound annual growth rate of -7.04%.

Market Cap History

Date	Market Cap	% Change
Apr 29, 2024	568.10M	2.10%
Apr 26, 2024	556.40M	1.24%
Apr 25, 2024	549.60M	-3.15%
Apr 24, 2024	567.50M	1.50%
Apr 23, 2024	559.10M	1.30%
Apr 22, 2024	551.90M	-0.59%
Apr 19, 2024	555.20M	0.29%
Apr 18, 2024	553.60M	-7.55%
Apr 17, 2024	598.80M	-1.02%
Apr 16, 2024	605.00M	-0.28%
Apr 15, 2024	606.70M	-0.08%
Apr 12, 2024	607.20M	-5.98%
Apr 11, 2024	645.80M	5.57%
Apr 10, 2024	611.70M	-5.12%
Apr 9, 2024	644.70M	2.30%
Apr 8, 2024	630.20M	5.33%
Apr 5, 2024	598.30M	1.80%
Apr 4, 2024	587.70M	-5.13%
Apr 3, 2024	619.50M	2.21%
Apr 2, 2024	606.10M	-0.46%
Apr 1, 2024	608.90M	-3.81%
Mar 28, 2024	633.00M	1.09%
Mar 27, 2024	626.20M	2.27%
Mar 26, 2024	612.30M	-0.18%
Mar 25, 2024	613.40M	-2.31%

View and export this data all the way back to 2020. Sign Up Today.

Related Stocks

Company	Market Cap
Cogent Biosciences	575.59M
Novavax	572.41M
Wave Life Sciences	569.84M
AnaptysBio	562.03M
Castle Biosciences	558.33M
IGM Biosciences	554.11M
Lyell Immunopharma	553.21M
GH Research	546.82M